Shu‐Jen Chang
Papers
1
Total Citations
6
H-Index
1
About
Dr. Shu-Jen Chang is a leading figure in the advancement of robotic radiotherapy, with a focused expertise in the development and clinical evaluation of multi-leaf collimator (MLC) systems for precision radiation delivery. Her most cited work, "SU-E-T-603: Evaluation of MLC-Based Robotic Radiotherapy," is a seminal study that assessed the transformative potential of integrating MLC technology into the CyberKnife M6 system. By conducting a multi-disease site analysis, Dr. Chang demonstrated how MLC-based beam shaping could significantly enhance conformal targeting in conventionally fractionated treatments, moving beyond the limitations of earlier fixed-cone approaches. This contribution, which has garnered 6 citations, laid critical groundwork for improving treatment accuracy and efficiency across a range of tumor sites. Her research directly addresses the challenge of delivering high-dose radiation while sparing healthy tissue, a core goal in modern radiation oncology. Dr. Chang’s work is particularly notable for bridging engineering innovation with clinical application, making her a key contributor to the evolution of robotic radiosurgery. Her findings continue to inform treatment planning protocols and inspire further optimization of MLC-based delivery systems.
Research Focus
Key Achievements
Top Papers
- 1SU‐E‐T‐603: Evaluation of MLC‐Based Robotic Radiotherapy6 citations · 2013